61755-005Level 3
EYLEA (aflibercept)
**Product type:** Human Prescription Drug
**Active ingredient:** AFLIBERCEPT
**Strength:** 40 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravitreal
**Labeler:** Regeneron Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA125387)
**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/61755-005Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.